Market Overview:
The global paroxetine hydrochloride tablet market is expected to register a CAGR of 5.5% during the forecast period, 2018-2030. The market growth can be attributed to the increasing prevalence of depression and anxiety disorders, rising geriatric population, and growing demand for effective treatment options. Based on type, the global paroxetine hydrochloride tablet market is segmented into 10mg per tablet, 20mg per tablet, 30mg per tablet, 40mg per tablet and others. Among these segments, the 10 mg per tablets segment is expected to account for a major share of the global market in 2018. This can be attributed to its lower dosage as compared to other segments and wide availability across regions. However, with increasing awareness about various dosage options available in the market among patients and healthcare professionals alike; 20 mg tablets are projected to witness highest growth rate during the forecast period. Based on application type; depression accounted for a majority share of revenue generated by this product in 2017 owing high prevalence rates coupled with growing demand for better treatment outcomes globally .However anxiety disorders are also gaining significant traction due high incidence rates along with unmet needs among patients suffering from these conditions which would fuel adoption over next few years .
Product Definition:
Paroxetine Hydrochloride Tablet is a type of antidepressant medication which is used to treat various types of depression. It works by helping to restore the balance of certain natural chemicals in the brain.
10mg Per Tablet:
10mg Per tablet is used for the treatment of major depressive disorder, panic disorder, phobias and social anxiety. It works by increasing serotonin levels in the brain which helps in improving mood as well as relieves pain.
The global paroxetine hydrochloride market is expected to grow at a significant rate owing to its use in various disorders such as post-traumatic stress disorder (PTSD), obsessive-compulsive disorder (OCD).
20mg Per Tablet:
20mg Per tablet is used for the treatment of Major Depressive Disorder (MDD) and anxiety disorders, such as panic disorder, phobias, obsessive-compulsive disorder (OCD), and posttraumatic stress disorder (PTSD). It is also used to treat symptoms of Alzheimer's disease.
The 20 mg per tablet dose for MDD is usually started at a low range and increased over a few weeks depending on the response of the patient.
Application Insights:
The global paroxetine hydrochloride tablet market by application is classified into treat depression, treat obsessive-compulsive disorder, and others. The other applications of paroxetine include anxiety treatment and post-traumatic stress disorder (PTSD). The global market for these disorders was valued at USD 585.0 million in 2016 and is expected to grow at a CAGR of XX% from 2017 to 2030 owing to the increasing prevalence of mental disorders globally coupled with rising healthcare spending on such diseases.
Regional Analysis:
Asia Pacific is expected to be the largest market for paroxetine hydrochloride tablets, in terms of revenue, followed by Europe. The presence of a large patient pool and increasing awareness levels are some factors contributing to the growth of this regional market. In 2016, India was one of the largest markets for prescription drugs with a shareof 24.5% in Asia Pacific and China was at 23rd position with respect to usage rate globally (The Indian Express). Thus, it can be said that India has one of the highest shares among all countries regarding usage rates for paroxetine hydrochloride tablets; thus making it an attractive market for global players operating in this space as well as new entrants looking to capitalize on growing demand.
In addition, regulatory authorities such as FDA have approved marketing claims made by manufacturers pertaining to treatment options offered through these tablets which further increases their consumption rates across various applications within APAC region thereby driving regional growth over the forecast period.
Growth Factors:
- Increasing prevalence of depression and anxiety disorders
- Growing awareness about the benefits of antidepressants
- Rising demand for convenient treatment options
- Availability of generic versions of paroxetine hydrochloride tablets
- Growing research and development investments in antidepressant therapies
Scope Of The Report
Report Attributes
Report Details
Report Title
Paroxetine Hydrochloride Tablet Market Research Report
By Type
10mg Per Tablet, 20mg Per Tablet, 30mg Per Tablet, 40mg Per Tablet, Others
By Application
Treat Depression, Treat Obsessive-Compulsive Disorder, Treat Anxiety, Others
By Companies
Medichem, HUAHAI PHARMACEUTICAL, Enaldrugs, Win Sunny, Gsk, JIANFENG Pharmaceutical, APOTEX, Mylan, Zydus Pharmaceutical
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
142
Number of Tables & Figures
100
Customization Available
Yes, the report can be customized as per your need.
Global Paroxetine Hydrochloride Tablet Market Report Segments:
The global Paroxetine Hydrochloride Tablet market is segmented on the basis of:
Types
10mg Per Tablet, 20mg Per Tablet, 30mg Per Tablet, 40mg Per Tablet, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Treat Depression, Treat Obsessive-Compulsive Disorder, Treat Anxiety, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Medichem
- HUAHAI PHARMACEUTICAL
- Enaldrugs
- Win Sunny
- Gsk
- JIANFENG Pharmaceutical
- APOTEX
- Mylan
- Zydus Pharmaceutical
Highlights of The Paroxetine Hydrochloride Tablet Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- 10mg Per Tablet
- 20mg Per Tablet
- 30mg Per Tablet
- 40mg Per Tablet
- Others
- By Application:
- Treat Depression
- Treat Obsessive-Compulsive Disorder
- Treat Anxiety
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Paroxetine Hydrochloride Tablet Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Paroxetine hydrochloride tablet is a medication used to treat depression. It works by increasing the levels of serotonin in the brain.
Some of the major companies in the paroxetine hydrochloride tablet market are Medichem, HUAHAI PHARMACEUTICAL, Enaldrugs, Win Sunny, Gsk, JIANFENG Pharmaceutical, APOTEX, Mylan, Zydus Pharmaceutical.
The paroxetine hydrochloride tablet market is expected to grow at a compound annual growth rate of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Paroxetine Hydrochloride Tablet Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Paroxetine Hydrochloride Tablet Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Paroxetine Hydrochloride Tablet Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Paroxetine Hydrochloride Tablet Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Paroxetine Hydrochloride Tablet Market Size & Forecast, 2020-2028
4.5.1 Paroxetine Hydrochloride Tablet Market Size and Y-o-Y Growth
4.5.2 Paroxetine Hydrochloride Tablet Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 10mg Per Tablet
5.2.2 20mg Per Tablet
5.2.3 30mg Per Tablet
5.2.4 40mg Per Tablet
5.2.5 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Treat Depression
6.2.2 Treat Obsessive-Compulsive Disorder
6.2.3 Treat Anxiety
6.2.4 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Paroxetine Hydrochloride Tablet Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Paroxetine Hydrochloride Tablet Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 10mg Per Tablet
9.6.2 20mg Per Tablet
9.6.3 30mg Per Tablet
9.6.4 40mg Per Tablet
9.6.5 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Treat Depression
9.10.2 Treat Obsessive-Compulsive Disorder
9.10.3 Treat Anxiety
9.10.4 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 10mg Per Tablet
10.6.2 20mg Per Tablet
10.6.3 30mg Per Tablet
10.6.4 40mg Per Tablet
10.6.5 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Treat Depression
10.10.2 Treat Obsessive-Compulsive Disorder
10.10.3 Treat Anxiety
10.10.4 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 10mg Per Tablet
11.6.2 20mg Per Tablet
11.6.3 30mg Per Tablet
11.6.4 40mg Per Tablet
11.6.5 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Treat Depression
11.10.2 Treat Obsessive-Compulsive Disorder
11.10.3 Treat Anxiety
11.10.4 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 10mg Per Tablet
12.6.2 20mg Per Tablet
12.6.3 30mg Per Tablet
12.6.4 40mg Per Tablet
12.6.5 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Treat Depression
12.10.2 Treat Obsessive-Compulsive Disorder
12.10.3 Treat Anxiety
12.10.4 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 10mg Per Tablet
13.6.2 20mg Per Tablet
13.6.3 30mg Per Tablet
13.6.4 40mg Per Tablet
13.6.5 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Treat Depression
13.10.2 Treat Obsessive-Compulsive Disorder
13.10.3 Treat Anxiety
13.10.4 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Paroxetine Hydrochloride Tablet Market: Competitive Dashboard
14.2 Global Paroxetine Hydrochloride Tablet Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Medichem
14.3.2 HUAHAI PHARMACEUTICAL
14.3.3 Enaldrugs
14.3.4 Win Sunny
14.3.5 Gsk
14.3.6 JIANFENG Pharmaceutical
14.3.7 APOTEX
14.3.8 Mylan
14.3.9 Zydus Pharmaceutical
